Study of sugar patterns in lupus anti-DNA antibodies
Part of Immune system & allergy, Skin clinical trials.
This study looks at the “sugar coating” on anti-DNA antibodies in people with lupus. The goal is to better understand these antibody patterns, which may help improve how lupus is studied or treated in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have lupus (LE D) as defined by the 2019 ACR/EULAR criteria
- You have a positive test for native (actual) anti-DNA antibodies
- You can join whether your lupus symptoms are calm or currently flaring
- You agree and can give oral informed consent for the study
- You are not taking part in another clinical trial that actively changes treatment or procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood and immune cell markers (autoantibodies and immune cell “signatures”) to better understand autoimmune conditions, including lupus. It may help researchers identify which markers are linked to disease and how immune cells respond after vaccination.
This study looks at specific immune antibodies (against C1s, HMGB1, and C1q) in adults with systemic lupus erythematosus, especially when lupus is actively affecting the kidneys. It may help researchers better understand what is driving active lupus and who could benefit from future treatments.
This study looks at how certain immune cells (natural killer T cells) behave in people with systemic lupus, by measuring specific immune receptor markers in blood. It may help researchers better understand lupus and how it can connect with other conditions like antiphospholipid syndrome or Sjögren’s.
This study follows people newly diagnosed with lupus (SLE) to understand how the disease develops over time. It looks at what happens before treatment starts or soon after diagnosis, and aims to improve care for lupus patients across Europe.
This study looks at immune cells in people with certain autoimmune diseases or immune deficiencies. The goal is to understand how these cells work, which may help improve future treatments.
This research study aims to better understand systemic lupus erythematosus (SLE), an autoimmune disease where the body's immune system attacks its own tissues. Researchers will evaluate patients with lupus, study genetic factors, and perform optional imaging tests to learn how the disease affects blood vessels and the heart.
Hear when a new Autoimmune Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.